Mr. Collard joined Veloxis in December of 2015 as the Chief Executive Officer. He has over 23 years of experience in the pharmaceutical industry.
Mr. Collard is currently a Board member of BioMarck Pharmaceuticals and Hilltop Home Foundation. In 2003, Mr. Collard founded Cornerstone Therapeutics, where he became Chairman and CEO; Cornerstone Therapeutics was later sold to Chiesi Farmaceutici (2014).
Mr. Collard started his career at Dura Pharmaceuticals where he served in numerous sales and marketing roles within the Company. He left Dura in 1998 and joined DJ Pharma, Inc, which was sold to Biovail in 2000.
Mr. Collard holds a B.S. in Engineering from the Southern College of Technology (now Southern Polytechnic State University) in Marietta, Georgia.
Nov 15, 2017
Q3 Report 2017 Investor Call